Curcumin, inflammation, and neurological disorders: How are they linked?
Alzheimer's disease
Curcumin
Inflammation
Neurological disorders
Parkinson's disease
Journal
Integrative medicine research
ISSN: 2213-4220
Titre abrégé: Integr Med Res
Pays: Netherlands
ID NLM: 101612707
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
24
02
2023
revised:
14
05
2023
accepted:
07
06
2023
medline:
4
9
2023
pubmed:
4
9
2023
entrez:
4
9
2023
Statut:
ppublish
Résumé
Despite the extensive research in recent years, the current treatment modalities for neurological disorders are suboptimal. Curcumin, a polyphenol found in We searched PubMed database for relevant publications on curcumin and its uses in treating neurological diseases. We also reviewed relevant clinical trials which appeared on searching PubMed database using 'Curcumin and clinical trials'. This review details the pleiotropic immunomodulatory functions and neuroprotective properties of curcumin, its derivatives and formulations in various preclinical and clinical investigations. The effects of curcumin on neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), brain tumors, epilepsy, Huntington's disorder (HD), ischemia, Parkinson's disease (PD), multiple sclerosis (MS), and traumatic brain injury (TBI) with a major focus on associated signalling pathways have been thoroughly discussed. This review demonstrates curcumin can suppress spinal neuroinflammation by modulating diverse astroglia mediated cascades, ensuring the treatment of neurological disorders.
Sections du résumé
Background
UNASSIGNED
Despite the extensive research in recent years, the current treatment modalities for neurological disorders are suboptimal. Curcumin, a polyphenol found in
Methods
UNASSIGNED
We searched PubMed database for relevant publications on curcumin and its uses in treating neurological diseases. We also reviewed relevant clinical trials which appeared on searching PubMed database using 'Curcumin and clinical trials'.
Results
UNASSIGNED
This review details the pleiotropic immunomodulatory functions and neuroprotective properties of curcumin, its derivatives and formulations in various preclinical and clinical investigations. The effects of curcumin on neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), brain tumors, epilepsy, Huntington's disorder (HD), ischemia, Parkinson's disease (PD), multiple sclerosis (MS), and traumatic brain injury (TBI) with a major focus on associated signalling pathways have been thoroughly discussed.
Conclusion
UNASSIGNED
This review demonstrates curcumin can suppress spinal neuroinflammation by modulating diverse astroglia mediated cascades, ensuring the treatment of neurological disorders.
Identifiants
pubmed: 37664456
doi: 10.1016/j.imr.2023.100968
pii: S2213-4220(23)00047-1
pmc: PMC10469086
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100968Informations de copyright
© 2023 Korea Institute of Oriental Medicine. Published by Elsevier B.V.
Références
J Biol Chem. 1992 Jan 15;267(2):1286-92
pubmed: 1530936
Epilepsia. 2019 Apr;60(4):605-614
pubmed: 30747999
Front Public Health. 2022 Nov 29;10:952161
pubmed: 36523572
F1000Prime Rep. 2014 Jun 02;6:46
pubmed: 24991423
Toxicol Appl Pharmacol. 2001 Dec 1;177(2):121-31
pubmed: 11740911
Mol Neurobiol. 2014 Feb;49(1):368-79
pubmed: 23934646
Lancet. 2022 Oct 15;400(10360):1363-1380
pubmed: 36116464
Sci Rep. 2022 Mar 4;12(1):3572
pubmed: 35246564
Complement Ther Clin Pract. 2020 Nov;41:101256
pubmed: 33147541
Neuro Oncol. 2014 Oct;16 Suppl 4:iv1-63
pubmed: 25304271
J Integr Med. 2021 Jul;19(4):300-310
pubmed: 33863692
Int Immunopharmacol. 2022 Jul;108:108736
pubmed: 35364429
Front Pharmacol. 2019 Feb 04;10:33
pubmed: 30778297
Cold Spring Harb Perspect Biol. 2017 Jul 5;9(7):
pubmed: 28062563
Indian J Exp Biol. 2016 Feb;54(2):133-41
pubmed: 26934781
Free Radic Biol Med. 2003 Dec 15;35(12):1632-44
pubmed: 14680686
Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):9108-9116
pubmed: 31696502
Brain Res. 2021 Sep 1;1766:147517
pubmed: 33991495
Antioxid Redox Signal. 2013 Sep 10;19(8):836-53
pubmed: 23547621
Immunogenetics. 2017 Jun;69(6):371-378
pubmed: 28478481
Antioxidants (Basel). 2021 Jun 02;10(6):
pubmed: 34199639
Lancet. 2015 Aug 22;386(9995):743-800
pubmed: 26063472
Indian J Pharm Sci. 2010 Mar;72(2):149-54
pubmed: 20838516
Phytother Res. 2008 Dec;22(12):1660-4
pubmed: 18661468
Eur J Neurol. 2019 Jan;26(1):27-40
pubmed: 30300457
Biochem Pharmacol. 2020 Aug;178:114066
pubmed: 32502496
Int Immunopharmacol. 2018 Aug;61:74-81
pubmed: 29852475
Int J Nanomedicine. 2018 May 25;13:3093-3103
pubmed: 29872296
BMC Neurosci. 2010 Apr 30;11:57
pubmed: 20433710
Fundam Clin Pharmacol. 2013 Apr;27(2):169-72
pubmed: 22044441
Int J Prev Med. 2021 Dec 01;12:161
pubmed: 35070194
Transl Neurosci. 2020 Sep 09;11(1):319-327
pubmed: 33335771
Spinal Cord. 2017 Jan;55(1):26-32
pubmed: 27324320
J Nanobiotechnology. 2022 Jul 14;20(1):322
pubmed: 35836190
Metab Brain Dis. 2022 Feb;37(2):343-357
pubmed: 35048324
Planta Med. 1983 Nov;49(3):185-7
pubmed: 6657788
J Immunol. 2008 Jun 15;180(12):8066-72
pubmed: 18523270
Neuron. 2019 May 22;102(4):899
pubmed: 31121127
J Neuroimmunol. 2019 Feb 15;327:15-21
pubmed: 30683426
Neuron. 2018 Jun 27;98(6):1141-1154.e7
pubmed: 29861287
J Alzheimers Dis. 2017;57(4):1171-1183
pubmed: 28304309
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3224-9
pubmed: 14978262
Dialogues Clin Neurosci. 2000 Sep;2(3):247-55
pubmed: 22034060
Br J Pharmacol. 2000 Jan;129(2):231-4
pubmed: 10694226
Clin Immunol. 2012 Jan;142(1):2-8
pubmed: 21458377
Pharm Biol. 2013 Dec;51(12):1572-8
pubmed: 24004105
Mol Neurobiol. 2018 Jun;55(6):5243-5254
pubmed: 28879423
Medicines (Basel). 2018 Nov 23;5(4):
pubmed: 30477087
AAPS J. 2015 Nov;17(6):1341-56
pubmed: 26335307
Brain Behav. 2020 Jul;10(7):e01655
pubmed: 32441492
Neuroscience. 2014 Jul 11;272:141-53
pubmed: 24785678
Vet Sci. 2021 Sep 12;8(9):
pubmed: 34564586
Pain Res Manag. 2019 Sep 2;2019:3173149
pubmed: 31565108
Pharmacol Rep. 2018 Dec;70(6):1158-1167
pubmed: 30340096
Neurosci Lett. 2007 Apr 6;416(1):49-54
pubmed: 17300872
Can J Physiol Pharmacol. 2016 Jul;94(7):699-708
pubmed: 27088818
Medicina (Kaunas). 2020 Jul 03;56(7):
pubmed: 32635279
Antioxidants (Basel). 2022 Apr 07;11(4):
pubmed: 35453412
Lancet. 2012 Dec 15;380(9859):2163-96
pubmed: 23245607
Neurosci Bull. 2012 Jun;28(3):253-8
pubmed: 22622825
Mol Neurobiol. 2019 Apr;56(4):2450-2465
pubmed: 30032423
Caspian J Intern Med. 2022 Winter;13(1):16-22
pubmed: 35178203
Environ Sci Pollut Res Int. 2022 Oct;29(49):74619-74631
pubmed: 35641736
Int J Mol Sci. 2020 Oct 03;21(19):
pubmed: 33023066
Brain. 2022 Mar 29;145(1):27-44
pubmed: 34677606
Lab Anim Res. 2018 Dec;34(4):317-328
pubmed: 30671121
Int J Mol Sci. 2022 Apr 15;23(8):
pubmed: 35457197
Inflammopharmacology. 2008 Apr;16(2):96-9
pubmed: 18408903
Iran J Pharm Res. 2020 Summer;19(3):310-320
pubmed: 33680032
Neuroscience. 2009 Jul 21;161(4):1037-44
pubmed: 19393301
Mol Neurodegener. 2012 Apr 04;7:12
pubmed: 22475209
Neurosci Lett. 2022 Sep 14;787:136821
pubmed: 35908626
Pharmacol Biochem Behav. 2013 Sep;110:238-44
pubmed: 23932920
J Neurosci. 1999 Dec 1;19(23):10428-37
pubmed: 10575040
Neurosci Lett. 2010 Jan 4;468(2):120-4
pubmed: 19879924
Synapse. 2021 Jun;75(6):e22196
pubmed: 33559220
J Surg Res. 2016 Nov;206(1):67-76
pubmed: 27916377
Neuropharmacology. 2015 Dec;99:156-67
pubmed: 26211978
Clin Neurol Neurosurg. 2022 Jul;218:107300
pubmed: 35636380
Brain Res Bull. 2012 Dec 1;89(5-6):185-90
pubmed: 22986236
Neuromolecular Med. 2014 Mar;16(1):106-18
pubmed: 24008671
Cell. 1996 Nov 1;87(3):493-506
pubmed: 8898202
Phytother Res. 2021 Dec;35(12):6862-6882
pubmed: 34528307
Int J Mol Sci. 2020 Dec 15;21(24):
pubmed: 33333883
Cell Physiol Biochem. 2017;43(6):2226-2241
pubmed: 29069652
Exp Neurol. 2006 Feb;197(2):309-17
pubmed: 16364299
Neural Regen Res. 2021 Apr;16(4):783-789
pubmed: 33063743
Nutr Neurosci. 2021 Apr;24(4):317-326
pubmed: 31241007
Neurotox Res. 2021 Jun;39(3):787-799
pubmed: 33860897
Chem Commun (Camb). 2022 Feb 17;58(15):2576-2579
pubmed: 35107458
J Cell Physiol. 2019 Aug;234(10):16953-16965
pubmed: 30847942
J Immunol. 2002 Jun 15;168(12):6506-13
pubmed: 12055272
J Neuroinflammation. 2014 Mar 27;11:59
pubmed: 24669820
Int J Mol Sci. 2022 Aug 04;23(15):
pubmed: 35955792
Endocr Metab Immune Disord Drug Targets. 2021;21(2):365-373
pubmed: 32727335
Epilepsia Open. 2022 Aug;7 Suppl 1:S121-S132
pubmed: 34862851
J Neurosci. 2004 Dec 1;24(48):10993-8
pubmed: 15574749
Pharmacol Biochem Behav. 2016 Nov - Dec;150-151:39-47
pubmed: 27619637
Rep Biochem Mol Biol. 2020 Apr;9(1):1-7
pubmed: 32821745
Biomedicines. 2022 Nov 13;10(11):
pubmed: 36428481
Nano Lett. 2022 Mar 23;22(6):2450-2460
pubmed: 35271279
Toxicol Appl Pharmacol. 2018 May 1;346:28-36
pubmed: 29571711
Neurorehabil Neural Repair. 2011 May;25(4):332-42
pubmed: 21343524
Life Sci. 2010 Nov 20;87(19-22):596-603
pubmed: 20840851
Epilepsy Res. 2019 Feb;150:7-16
pubmed: 30605865
Eur J Pharmacol. 2013 Mar 15;704(1-3):33-40
pubmed: 23461849
Epilepsy Res. 2022 Mar;181:106873
pubmed: 35180639
Int Immunopharmacol. 2011 Mar;11(3):323-30
pubmed: 20828641
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
Int Immunopharmacol. 2023 Feb;115:109726
pubmed: 36641890
J Mol Neurosci. 2012 Jun;47(2):234-42
pubmed: 22418789
J Biol Chem. 2017 Dec 1;292(48):19656-19673
pubmed: 28972171
Brain. 2017 Mar 1;140(3):527-546
pubmed: 27794524
Front Mol Biosci. 2018 Apr 11;5:36
pubmed: 29696147
Free Radic Res. 2005 Oct;39(10):1119-25
pubmed: 16298737
Med Sci Monit. 2019 Jul 09;25:5087-5097
pubmed: 31287810
Br J Pharmacol. 1998 Jun;124(3):425-7
pubmed: 9647462
Pharmaceutics. 2021 Nov 16;13(11):
pubmed: 34834352
Int J Nanomedicine. 2019 Jun 17;14:4449-4460
pubmed: 31417253
Heliyon. 2022 Jul 06;8(7):e09896
pubmed: 35855984
Rejuvenation Res. 2010 Feb;13(1):55-64
pubmed: 20230279
Mol Pharm. 2007 Nov-Dec;4(6):807-18
pubmed: 17999464
Indian J Physiol Pharmacol. 2009 Jan-Mar;53(1):39-46
pubmed: 19810575
CNS Neurol Disord Drug Targets. 2022;21(10):994-1003
pubmed: 34939554
Eur Rev Med Pharmacol Sci. 2013 May;17(10):1360-8
pubmed: 23740450
Biomed Mater Eng. 2015;26 Suppl 1:S841-50
pubmed: 26406082
Alzheimers Res Ther. 2012 Oct 29;4(5):43
pubmed: 23107780
Ann Transl Med. 2020 Feb;8(4):88
pubmed: 32175381
Sci Rep. 2018 Feb 8;8(1):2645
pubmed: 29422541
Phytomedicine. 2011 Jun 15;18(8-9):756-9
pubmed: 21211953
Lancet Neurol. 2018 Jan;17(1):94-102
pubmed: 29154141
Molecules. 2020 Dec 08;25(24):
pubmed: 33302541
Sci Rep. 2016 Jan 05;6:18736
pubmed: 26728250
CNS Neurosci Ther. 2010 Oct;16(5):285-97
pubmed: 20406252
Neurosci Lett. 2011 Feb 11;489(3):192-6
pubmed: 21167259
J Tissue Eng Regen Med. 2020 Oct;14(10):1449-1464
pubmed: 32750189
ACS Omega. 2021 Mar 02;6(10):6654-6662
pubmed: 33748578
Front Cell Neurosci. 2022 Jun 14;16:884813
pubmed: 35774084
Neurotherapeutics. 2018 Apr;15(2):430-438
pubmed: 29352425
Molecules. 2021 Dec 31;27(1):
pubmed: 35011468
J Neuroimmunol. 2011 May;234(1-2):7-18
pubmed: 21474189
CNS Neurol Disord Drug Targets. 2018;17(10):767-779
pubmed: 30033879
Nanomaterials (Basel). 2022 Feb 24;12(5):
pubmed: 35269246
Neurotox Res. 2022 Oct;40(5):1272-1291
pubmed: 35781221
Neurochem Res. 2016 Nov;41(11):3113-3128
pubmed: 27535828
Chronobiol Int. 2021 Jan;38(1):61-78
pubmed: 33334207
Neurology. 2015 Feb 17;84(7):688-95
pubmed: 25609757
J Neurosci. 1999 Apr 15;19(8):3248-57
pubmed: 10191337
Bioessays. 2004 May;26(5):485-96
pubmed: 15112229
Phytother Res. 2021 Dec;35(12):6768-6801
pubmed: 34498308
J Integr Neurosci. 2021 Dec 30;20(4):895-903
pubmed: 34997713
Acta Neuropathol. 2008 Apr;115(4):479-89
pubmed: 18189141
Can J Physiol Pharmacol. 2017 May;95(5):501-509
pubmed: 28177687
J Psychiatry Neurosci. 2006 Jan;31(1):21-9
pubmed: 16496032
Life Sci. 2018 Oct 15;211:252-260
pubmed: 30243647
Int Immunopharmacol. 2020 Sep;86:106720
pubmed: 32585605
Molecules. 2022 Jan 25;27(3):
pubmed: 35164043
Endocr Metab Immune Disord Drug Targets. 2019;19(6):874-884
pubmed: 30760195
Alzheimers Dement (Amst). 2021 Aug 17;13(1):e12199
pubmed: 34430703
Cancer Metastasis Rev. 2022 Dec 8;:
pubmed: 36482154
Nat Rev Neurosci. 2012 Feb 22;13(4):267-78
pubmed: 22353781
J Nutr Biochem. 2012 Nov;23(11):1498-507
pubmed: 22402368
Hum Mol Genet. 2003 Oct 15;12 Spec No 2:R187-93
pubmed: 12925571
Neuropharmacology. 2002 Jun;42(8):1056-64
pubmed: 12128007
J Cell Mol Med. 2021 Sep;25(18):8947-8956
pubmed: 34405526
J Cell Physiol. 2018 Jul;233(7):5222-5230
pubmed: 29194612
J Tradit Complement Med. 2018 Oct 10;9(4):346-352
pubmed: 31453131
Nature. 2006 Oct 19;443(7113):787-95
pubmed: 17051205
Anticancer Agents Med Chem. 2012 Dec;12(10):1159-84
pubmed: 22583402
BMC Res Notes. 2021 Jul 23;14(1):283
pubmed: 34301320
Front Biosci (Schol Ed). 2022 May 7;14(2):13
pubmed: 35730438
Life Sci. 2019 Sep 15;233:116695
pubmed: 31351082
Lancet. 2021 Apr 17;397(10283):1505-1518
pubmed: 33773612
Exp Neurol. 2017 Dec;298(Pt B):162-171
pubmed: 28526239
Pharmacol Res. 2011 May;63(5):439-44
pubmed: 21237271
Neurochem Res. 2011 Nov;36(11):2195-204
pubmed: 21751034
Mol Cell Biochem. 2020 Feb;465(1-2):89-102
pubmed: 31820278
Biochem Pharmacol. 2009 Jul 15;78(2):178-83
pubmed: 19464433
Free Radic Res. 2012 May;46(5):637-44
pubmed: 22313459
Vet Res Forum. 2021 Winter;12(1):47-52
pubmed: 33953873
ACS Nano. 2022 Jan 25;16(1):869-884
pubmed: 34985280
Semin Neurol. 2016 Apr;36(2):103-14
pubmed: 27116717
Mov Disord. 2016 Jun;31(6):791-801
pubmed: 26923732
J Complement Integr Med. 2018 Mar 23;15(3):
pubmed: 29570450
Biomed Res Int. 2017;2017:4754701
pubmed: 29204441
Physiol Rev. 2010 Jul;90(3):905-81
pubmed: 20664076
Int J Neurosci. 2012 May;122(5):263-70
pubmed: 22176529
Chin Med J (Engl). 2012 Jun;125(11):1975-9
pubmed: 22884064
Biomed Pharmacother. 2021 Jul;139:111651
pubmed: 34243602
Apoptosis. 2006 Jun;11(6):943-53
pubmed: 16547587
Biomed J. 2013 Mar-Apr;36(2):40-50
pubmed: 23644232
CNS Neurol Disord Drug Targets. 2018 Mar 13;16(10):1120-1126
pubmed: 29237386
Saudi J Biol Sci. 2013 Apr;20(2):155-62
pubmed: 23961231
Am J Geriatr Psychiatry. 2018 Mar;26(3):266-277
pubmed: 29246725
J Mol Neurosci. 2021 Sep;71(9):1725-1742
pubmed: 33956297
Am J Transl Res. 2021 Dec 15;13(12):13380-13393
pubmed: 35035682
Oxid Med Cell Longev. 2016;2016:9324085
pubmed: 27807473
Neuroscience. 2015 Dec 3;310:362-71
pubmed: 26415768
Free Radic Res. 2020 Dec;54(11-12):918-930
pubmed: 32623920
Cell. 1993 Mar 26;72(6):971-83
pubmed: 8458085
J Neuroimmunol. 2019 Dec 15;337:577067
pubmed: 31629984
Antioxidants (Basel). 2021 Oct 11;10(10):
pubmed: 34679727
PLoS One. 2022 Mar 18;17(3):e0265689
pubmed: 35303012
Semin Cancer Biol. 2022 May;80:1-17
pubmed: 31866476
Headache. 2019 Mar;59(3):306-338
pubmed: 30589090
Neurology. 2019 May 7;92(19):e2250-e2260
pubmed: 30996060
P T. 2012 Mar;37(3):175-84
pubmed: 22605909
Int Immunopharmacol. 2022 Jul;108:108901
pubmed: 35729834
Pharmacol Biochem Behav. 2011 Sep;99(3):399-407
pubmed: 21641922
World Neurosurg. 2018 Jun;114:e785-e791
pubmed: 29567290
Antioxidants (Basel). 2021 Dec 24;11(1):
pubmed: 35052532
Plant Foods Hum Nutr. 2002 Winter;57(1):41-52
pubmed: 11855620
Eur Rev Med Pharmacol Sci. 2006 Jul-Aug;10(4):157-61
pubmed: 16910344
ACS Pharmacol Transl Sci. 2021 Mar 17;4(2):647-665
pubmed: 33860191
Phytomedicine. 2023 Jan;108:154520
pubmed: 36334386
Neurochem Res. 2021 Dec;46(12):3166-3178
pubmed: 34401962
Antioxidants (Basel). 2022 Apr 25;11(5):
pubmed: 35624701
Drug Dev Res. 2019 Aug;80(5):629-636
pubmed: 31033006
Molecules. 2021 May 18;26(10):
pubmed: 34070220
N Engl J Med. 2000 Sep 28;343(13):938-52
pubmed: 11006371
Int Immunopharmacol. 2009 May;9(5):575-81
pubmed: 19539560
Lancet Neurol. 2022 Jul;21(7):645-658
pubmed: 35716694
Biochim Biophys Acta. 2015 May;1854(5):426-36
pubmed: 25666897
Curr Treat Options Neurol. 2019 Mar 14;21(4):14
pubmed: 30868470
Biofactors. 2013 Jan-Feb;39(1):122-32
pubmed: 23303664
Br J Pharmacol. 2017 Jun;174(11):1325-1348
pubmed: 27638428
J Biol Chem. 2008 May 23;283(21):14497-505
pubmed: 18362141
Neurotox Res. 2022 Apr;40(2):449-460
pubmed: 35192145
Adv Exp Med Biol. 2021;1291:363-373
pubmed: 34331701
Pharmacol Biochem Behav. 2014 Oct;125:55-64
pubmed: 25117510
Epilepsy Behav. 2009 Feb;14(2):300-8
pubmed: 19100339
Biomaterials. 2020 Jul;245:119987
pubmed: 32229332
J Neurosci. 2009 Jul 15;29(28):9078-89
pubmed: 19605645
Cancer. 2013 Oct 1;119(19):3489-95
pubmed: 23868553
J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):540-549
pubmed: 28057713
Indian J Med Sci. 1972 Apr;26(4):269-70
pubmed: 4637293
Exp Gerontol. 2006 Apr;41(4):346-59
pubmed: 16564662
Biomed Pharmacother. 2022 Oct;154:113621
pubmed: 36055110
Cell Tissue Bank. 2023 Mar;24(1):75-91
pubmed: 35641803
J Clin Med. 2020 Apr 08;9(4):
pubmed: 32276438
BMC Res Notes. 2022 May 23;15(1):189
pubmed: 35606882
Int J Mol Sci. 2021 Jun 15;22(12):
pubmed: 34203960
Brain Res Bull. 2018 Jun;140:65-71
pubmed: 29626606
Neurotox Res. 2021 Jun;39(3):815-825
pubmed: 33713300
Alzheimers Res Ther. 2021 Feb 8;13(1):37
pubmed: 33557949
Neurochem Int. 2015 Oct;89:40-50
pubmed: 26190183
Lancet. 2019 Feb 16;393(10172):689-701
pubmed: 30686584
Hum Mol Genet. 2019 Dec 1;28(23):4012-4021
pubmed: 31630202
J Neurochem. 2010 May;113(3):637-48
pubmed: 20132469
Nat Rev Immunol. 2017 Sep;17(9):545-558
pubmed: 28580957
Exp Biol Med (Maywood). 2022 Jan;247(2):152-164
pubmed: 34743577
Neurochem Int. 2022 May;155:105297
pubmed: 35122926
Pathol Res Pract. 2016 Apr;212(4):247-51
pubmed: 26922613
J Nanobiotechnology. 2020 May 13;18(1):71
pubmed: 32404183
CNS Neurol Disord Drug Targets. 2018;17(6):430-438
pubmed: 29938621
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Chin Med J (Engl). 2009 Jun 20;122(12):1435-8
pubmed: 19567167
Chem Biol Interact. 2011 Nov 15;194(2-3):139-47
pubmed: 22020177
Annu Rev Neurosci. 2003;26:627-56
pubmed: 12704223
Stem Cells Int. 2020 Feb 17;2020:4636397
pubmed: 32148518
Int J Mol Sci. 2020 Dec 22;22(1):
pubmed: 33374919
Phytother Res. 2020 Dec;34(12):3180-3188
pubmed: 32542818
Neuroimmunomodulation. 2017;24(6):348-355
pubmed: 29669346
Front Aging Neurosci. 2022 Oct 10;14:937486
pubmed: 36299608